56 related articles for article (PubMed ID: 31675923)
1. The diversity of peripheral blood T cells and myeloid-derived suppressor cells in patients with idiopathic membranous nephropathy.
Shi X; Zhang M; Wang G; Chen G; Hu R; Lee X; Li X
Clin Nephrol; 2024 Jun; 101(6):287-297. PubMed ID: 38511675
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of circulating myeloid-derived suppressor cell subsets: predicting poor clinical efficacy and prognosis through T cell suppression in non-Hodgkin's lymphoma.
Pu LF; Li MM; Feng XJ; Zhang T; Hu LH; Zheng HM; Charwudzi A; Ding YY; Liu J; Liu ZL; Xiong SD
J Leukoc Biol; 2024 May; 115(6):1094-1107. PubMed ID: 38369808
[TBL] [Abstract][Full Text] [Related]
3. The clinical association of programmed death-1/PD-L1 axis, myeloid derived suppressor cells subsets and regulatory T cells in peripheral blood of stable COPD patients.
Zhang M; Wan Y; Han J; Li J; Gong H; Mu X
PeerJ; 2024; 12():e16988. PubMed ID: 38560459
[TBL] [Abstract][Full Text] [Related]
4. Myeloid-derived suppressor cells impede T cell functionality and promote Th17 differentiation in oral squamous cell carcinoma.
Dar AA; Patil RS; Pradhan TN; Chaukar DA; D'Cruz AK; Chiplunkar SV
Cancer Immunol Immunother; 2020 Jun; 69(6):1071-1086. PubMed ID: 32103293
[TBL] [Abstract][Full Text] [Related]
5. Reduced Expression of Autophagy Markers and Expansion of Myeloid-Derived Suppressor Cells Correlate With Poor T Cell Response in Severe COVID-19 Patients.
Tomić S; Đokić J; Stevanović D; Ilić N; Gruden-Movsesijan A; Dinić M; Radojević D; Bekić M; Mitrović N; Tomašević R; Mikić D; Stojanović D; Čolić M
Front Immunol; 2021; 12():614599. PubMed ID: 33692788
[TBL] [Abstract][Full Text] [Related]
6. Arginase-1-dependent promotion of TH17 differentiation and disease progression by MDSCs in systemic lupus erythematosus.
Wu H; Zhen Y; Ma Z; Li H; Yu J; Xu ZG; Wang XY; Yi H; Yang YG
Sci Transl Med; 2016 Mar; 8(331):331ra40. PubMed ID: 27009269
[TBL] [Abstract][Full Text] [Related]
7. Tumor-infiltrating monocytic myeloid-derived suppressor cells contribute to the development of an immunosuppressive tumor microenvironment in gastric cancer.
Tsutsumi C; Ohuchida K; Katayama N; Yamada Y; Nakamura S; Okuda S; Otsubo Y; Iwamoto C; Torata N; Horioka K; Shindo K; Mizuuchi Y; Ikenaga N; Nakata K; Nagai E; Morisaki T; Oda Y; Nakamura M
Gastric Cancer; 2024 Mar; 27(2):248-262. PubMed ID: 38217732
[TBL] [Abstract][Full Text] [Related]
8. Detection of myeloid-derived suppressor cells by flow cytometry.
Liu T; Rosek A; Gonzalez De Los Santos F; Phan SH
Methods Cell Biol; 2024; 184():1-15. PubMed ID: 38555150
[TBL] [Abstract][Full Text] [Related]
9. Circulating myeloid-derived suppressor cells may be a useful biomarker in the follow-up of unvaccinated COVID-19 patients after hospitalization.
Jiménez-Cortegana C; Salamanca E; Palazón-Carrión N; Sánchez-Jiménez F; Pérez-Pérez A; Vilariño-García T; Fuentes S; Martín S; Jiménez M; Galván R; Rodríguez-Chacón C; Sánchez-Mora C; Moreno-Mellado E; Gutiérrez-Gutiérrez B; Álvarez N; Sosa A; Garnacho-Montero J; de la Cruz-Merino L; Rodríguez-Baño J; Sánchez-Margalet V
Front Immunol; 2023; 14():1266659. PubMed ID: 38035104
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of biomarkers for severe dengue infections.
Soo KM; Khalid B; Ching SM; Tham CL; Basir R; Chee HY
PeerJ; 2017; 5():e3589. PubMed ID: 28929009
[TBL] [Abstract][Full Text] [Related]
11. Continuous renal replacement therapy attenuates polymorphonuclear myeloid-derived suppressor cell expansion in pediatric severe sepsis.
Feng S; Cui Y; Zhou Y; Shao L; Miao H; Dou J; Liu T; Wang C; Zhang Y
Front Immunol; 2022; 13():990522. PubMed ID: 36263056
[TBL] [Abstract][Full Text] [Related]
12. Ferrets as a model for tuberculosis transmission.
Gupta T; Somanna N; Rowe T; LaGatta M; Helms S; Owino SO; Jelesijevic T; Harvey S; Jacobs W; Voss T; Sakamoto K; Day C; Whalen C; Karls R; He B; Tompkins SM; Bakre A; Ross T; Quinn FD
Front Cell Infect Microbiol; 2022; 12():873416. PubMed ID: 36051240
[TBL] [Abstract][Full Text] [Related]
13. High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19.
Lourda M; Dzidic M; Hertwig L; Bergsten H; Palma Medina LM; Sinha I; Kvedaraite E; Chen P; Muvva JR; Gorin JB; Cornillet M; Emgård J; Moll K; García M; Maleki KT; Klingström J; Michaëlsson J; Flodström-Tullberg M; Brighenti S; Buggert M; Mjösberg J; Malmberg KJ; Sandberg JK; Henter JI; Folkesson E; Gredmark-Russ S; Sönnerborg A; Eriksson LI; Rooyackers O; Aleman S; Strålin K; Ljunggren HG; Björkström NK; Svensson M; Ponzetta A; Norrby-Teglund A; Chambers BJ;
Proc Natl Acad Sci U S A; 2021 Oct; 118(40):. PubMed ID: 34548411
[TBL] [Abstract][Full Text] [Related]
14. Elevated frequencies of CD14
Xue G; Jiang M; Zhao R; Le A; Li J
Aging (Albany NY); 2021 Feb; 13(5):6236-6246. PubMed ID: 33640878
[TBL] [Abstract][Full Text] [Related]
15. Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5/14.
Murch SH
Med Hypotheses; 2020 Nov; 144():110168. PubMed ID: 33254494
[TBL] [Abstract][Full Text] [Related]
16. The clinical significance of myeloid-derived suppressor cells in dengue fever patients.
Guo PL; Li LH; Li WL; Zhao JC; Hu FY; Zhang FC; Cai WP; Tang XP
BMC Infect Dis; 2019 Nov; 19(1):926. PubMed ID: 31675923
[TBL] [Abstract][Full Text] [Related]
17. Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer.
Safarzadeh E; Hashemzadeh S; Duijf PHG; Mansoori B; Khaze V; Mohammadi A; Kazemi T; Yousefi M; Asadi M; Mohammadi H; Babaie F; Baradaran B
J Cell Physiol; 2019 Apr; 234(4):3515-3525. PubMed ID: 30362521
[TBL] [Abstract][Full Text] [Related]
18. Human splenic myeloid derived suppressor cells: Phenotypic and clustering analysis.
Cole KE; Ly QP; Hollingsworth MA; Cox JL; Padussis JC; Foster JM; Vargas LM; Talmadge JE
Cell Immunol; 2021 May; 363():104317. PubMed ID: 33714729
[TBL] [Abstract][Full Text] [Related]
19. Expansion and activation of monocytic-myeloid-derived suppressor cell via STAT3/arginase-I signaling in patients with ankylosing spondylitis.
Liu YF; Zhuang KH; Chen B; Li PW; Zhou X; Jiang H; Zhong LM; Liu FB
Arthritis Res Ther; 2018 Aug; 20(1):168. PubMed ID: 30075733
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]